Investment
UTokyo IPC is actively investing the startups
who wish to connect to the University of Tokyo.
If you are seeking an investment support from UTokyo IPC, please contact us.
Investment strategy
UTokyo IPC is responsible of both pursuing returns to
its investments as a funding company and also
giving the academic and educational research results
from the University of Tokyo back to society.
Through the investment activities,
the University of Tokyo aims to contribute
to achieve ESG (Environment, Social, Governance) and SDGs (Sustainable Development Goals)
as one of the pioneers in academic industry with keeping
its hope of achieving fairness of the world.
Our funds
Establishment: December 2016
Period: 15 years
Size: 25 billion yen
Purpose: Direct investment in UTokyo-related startups
Investment in funds of venture capitals
Establishment： 2020
Period: 15 years
Size：Approximately 28M USD
(Increase of the size is planned)
Purpose：Investment for JV formation and curve out execution.
Investment for unmatured seeds that already has particular alliance with business company.
LP investors
(Limited Partners)
-
National universityThe University of Tokyo
-
BankSumitomo Mitsui Banking Corporation
-
BankMUFG Bank, Ltd.
Portfolio startups
Life Sciences
-
Business outline
"the world’s first head-mounted automated visual-field testing equipment"CREWT Medical Systems, Inc.
-
Business outline
"Nucleic acid drug delivery system"AccuRna, Inc.
-
Business outline
"Drug development of DNA aptamer using artificial DNA base pair"TAGCyx Biotechnologies, Inc.
-
Business outline
"DDS that can pass through the cerebrovascular barrier"Braizon Therapeutics, Inc.
-
Business outline
Drug development using proprietary technologies on CRISPR and protein engineering platformsModalis Therapeutics Corporation (formerly “EdiGENE”)
-
Business outline
Networked drug discovery company that makes full use of cutting-edge drug discovery technologiesModulus Discovery, Inc.
-
Business outline
Development of medical device for the treatment of acute myocardial infarctionAdriakaim Inc.
-
Business outline
Development of drugs with a mechanism of action to induce proteolysis.FIMECS, Inc.
-
Development therapeutic antibodies and diagnostics in oncology and other disease area.RIN Institute Inc.
Space
-
Business outline
"Development and operation of small SAR satellite"Synspective Inc.
-
Business outline
"Development and operation of small optical satellite"Axelspace Corporation
-
Business outline
"Collection of space debris・On-Orbit-Services"Astroscale Holdings Inc.
Hardware
-
Business outline
"Wearable device using flexible wiring"Xenoma Inc.
-
Business outline
"Development of remote control and intelligent robot"TELEXISTENCE inc.
-
Business outline
”Silicon photonics and laser eyewear for low vision aid”QD Laser, Inc.
-
Business outline
Delivery of industrial proof Lasers for high quality micro-machiningSpectronix Corporation
-
Business outline
Developing powered prosthetic legs for people with disabilitiesBionicM Inc.
-
Business outline
Development and sales of fully automated agricultural cultivation machinesHarvestX Inc.
IT & Software
-
Business outline
Fully automated wealth management serviceWealthNavi, Inc.
-
Business outline
Childcare platform and cross-border e-commerce supportOnedot Inc.
-
Business outline
Accelerating Digital Transformation through ”Co-creation R&D” servicesBIRD INITIATIVE, Inc.
AI
-
Business outline
Development of robotic cooking system and salesConnected Robotics Inc.
-
Business outline
AI online learning service / AI project supportAidemy Inc.
-
Establishment of realtime digital twin tool for inspection of road conditionUrbanX Technologies, Inc.
Portfolio venture capital funds
-
Major investment area
"Life Science, ICT, Manufacturing"The University of Tokyo Edge Capital Partners Co., Ltd.
-
Major investment area
"Life Science"Fast Track Initiative, Inc.
-
Major investment area
"Life Science, ICT, Manufacturing"Beyond Next Ventures Inc.
-
Major investment area
"ICT, Manufacturing, FinTech"Global Brain Corporation
-
Major investment area: Life science focusing on development of medical drugsREMIGES VENTURES, Inc.
-
Major investment area
"ICT, Manufacturing"360ip Japan, KK